Creating a Sustainable Reimbursement Model for Ultra-Rare Therapies

Rich Horgan, founder and president of Cure Rare Disease, discusses the evolution of his organization, its growing pipeline of therapies, and why developing a viable reimbursement model is essential to creating sustainable development of ultra-rare disease therapies.